EVIDENCE OF TOLERANCE DEVELOPMENT TO THE HYPERPHAGIC BUT NOT ANXIOLYTIC-LIKE ACTIONS OF SB-200646A, A 5-HT2C/5-HT2B RECEPTOR ANTAGONIST, AFTER CHRONIC TREATMENT

被引：0
|
作者：
KENNETT, GA [1 ]
GREWAL, S [1 ]
BLACKBURN, TP [1 ]
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AW,ESSEX,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P370 / P370
页数：1
相关论文
共 50 条
  • [21] The 5HT(2C/2B) receptor antagonist, SB 206553, has anxiolytic-like properties in two rat models
    Kennett, GA
    Bright, F
    DArcy, S
    Blackburn, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P16 - P16
  • [22] Simplified analogues of ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors
    Claudi, F
    Scoccia, L
    Giorgioni, G
    Marucci, G
    Di Stefano, A
    Gessi, S
    Siniscalchi, A
    Borea, PA
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (09) : 705 - 713
  • [23] Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment
    Jarmo Hietala
    Mikko Kuoppamäki
    Hannu Majasuo
    Esa-Pekka Pälvimäki
    Aki Laakso
    Erkka Syvälahti
    Psychopharmacology, 2001, 157 : 180 - 187
  • [24] Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment
    Hietala, J
    Kuoppamäki, M
    Majasuo, H
    Pälvimäki, EP
    Laakso, A
    Syvälahti, E
    PSYCHOPHARMACOLOGY, 2001, 157 (02) : 180 - 187
  • [25] The acute and chronic administration of the 5-HT2B/2C receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat:: An in vivo extracellular single cell study
    Blackburn, TP
    Suzuki, K
    Ashby, CR
    SYNAPSE, 2006, 59 (08) : 502 - 512
  • [26] SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist
    Kennett, GA
    Wood, MD
    Bright, F
    Trail, B
    Riley, G
    Holland, V
    Avenell, KY
    Stean, T
    Upton, N
    Bromidge, S
    Forbes, IT
    Brown, AM
    Middlemiss, DN
    Blackburn, TP
    NEUROPHARMACOLOGY, 1997, 36 (4-5) : 609 - 620
  • [27] Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors
    Knight, AR
    Misra, A
    Quirk, K
    Benwell, K
    Revell, D
    Kennett, G
    Bickerdike, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (02) : 114 - 123
  • [28] Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors
    Antony R. Knight
    Anil Misra
    Kathleen Quirk
    Karen Benwell
    Dean Revell
    Guy Kennett
    Mike Bickerdike
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 370 : 114 - 123
  • [29] Comparative modulation of hippocampal 5-HT release by the 5-HT2C receptor antagonist SB 206553 and paroxetine
    Thorn, L
    Routledge, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P257 - P257
  • [30] Chronic treatment with SSRIs desensitizes both 5-HT2A and 5-HT2C receptor function
    Yamauchi, Miki
    Miyara, Takako
    Matsushima, Tetsuya
    Tatebayashi, Tomoko
    Yokoyama, Fumikazu
    Onozawa, Kaname
    Yoshida, Akiko
    Imanishi, Taiichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 84 - 84
12345